Overview

Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Status:
Completed

Trial end date:
2020-07-29

Target enrollment:

Participant gender:

Summary

A bioequivalence and food-effect study comparing two tablet formulations of tebipenem pivoxil hydrobromide (TBPM-PI-HBr) in healthy adult subjects.

Phase:

Phase 1

Details

Lead Sponsor:

Spero Therapeutics